Pharmaceuticals Projects in India – Page 7

1,542 upcoming and ongoing pharmaceuticals projects in India worth ₹665,172 Cr, with investment, location, project stage and latest status. Last updated 08 Oct 2026.

Projects tracked
1,542
Total investment
₹665,172 Cr
Pre-project / Under construction
0 / 0
Added in the last 30 days
14

Latest pharmaceuticals projects in India

Showing 31–35 of 1,542
  1. Pre Project Stage Pharmaceuticals Projects Updated

    Rs.950 Million New Bulk Drugs & Drug Intermediates Mfg. Facility in Satara, Maharashtra

    Maharashtra From 100 Million to 999 Million

    A new bulk drugs and drug intermediates (API) manufacturing facility of 6,950 MT/A capacity is proposed at Village Atit, Tal. Satara, Dist. Satara, Maharashtra, on a 4.57 Ha plot, designed on a Zero Liquid Discharge (ZLD) basis. The project has received Standard ToR from MoEFCC and is at the pre-construction stage, with baseline environmental data collection already completed

    View project
  3. Announcement Stage Pharmaceuticals Projects Updated

    Rs.1500 Million New Pharmaceutical Manufacturing Facility in Hyderabad, Telangana

    Telangana From 1000 Million to 4999 Million

    A new manufacturing facility is being planned at Genome Valley in Hyderabad with an investment of around Rs 150 crore. The plant will produce existing pharmaceutical products along with upcoming nano-formulation products, including a nano-carrier Vitamin D3 oral dispersion that recently received DCGI approval. The facility is expected to be completed in about two years.

    View project
  4. Under Implementation Pharmaceuticals Projects Updated

    API and API Intermediates Manufacturing Project in Bharuch, Gujarat

    Gujarat Less than 100 Million

    A synthetic organic chemicals (API and API intermediates) manufacturing unit is proposed at Saykha GIDC, Bharuch, Gujarat, with a total proposed capacity of around 200 MT/month plus 0.1 MT/month for R&D. The unit already holds an earlier Environmental Clearance and Consent to Establish, with the current filing being a fresh EC application for expansion, presently under verification with SEIAA/SCEIA. Products planned include Bosentan Monohydrate, Cilostazol, 2-Amino-6-Hydroxypurine, Celecoxib and Fluconazole, among others.

    View project
  5. Under Implementation Pharmaceuticals Projects Updated

    Rs.200 Million Bulk Drug, Intermidiates Mfg. Expansion Project in Solapur, Maharashtra

    Maharashtra From 100 Million to 999 Million

    A bulk drug and intermediates manufacturing unit in Chincholi MIDC, Solapur, Maharashtra, is set for expansion to a capacity of 22,242 TPA, including allied products like flavors and fragrances. The project, estimated at Rs. 67.5 million, is scheduled for construction from December 2025 to July 2027. Environmental clearance is currently under review by the State Authority.

    View project